# A Single Blind Study to Evaluate the Safety, Tolerability and Explore the Efficacy of 8.0 mg ASM8 Inhaled Daily for 14 Days in Severe Asthma

> **NCT01380236** · PHASE2 · WITHDRAWN · sponsor: **Syntara**

## Conditions studied

- Asthma

## Interventions

- **DRUG:** ASM8

## Key facts

- **NCT ID:** NCT01380236
- **Lead sponsor:** Syntara
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-11
- **Primary completion:** 2012-06
- **Final completion:** 2013-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Protocol not progressed. Study not implemented.
- **Last updated:** 2012-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01380236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01380236, "A Single Blind Study to Evaluate the Safety, Tolerability and Explore the Efficacy of 8.0 mg ASM8 Inhaled Daily for 14 Days in Severe Asthma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01380236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*